title: [Pharmacogenetic studies: evaluation guidelines for research ethics committees. Study protocol and patient information sheet (II)].
authors.affiliation: Departamento Médico. GlaxoSmithKline S.A. Tres Cantos. Madrid. Spain. jrv76999@gsk.com
authors.forename: Julio
authors.initials: J
authors.lastname: Rodríguez-Villanueva
authors.forename: M Jesús
authors.initials: MJ
authors.lastname: Alsar
authors.forename: Cristina
authors.initials: C
authors.lastname: Avendaño
authors.forename: Cristina
authors.initials: C
authors.lastname: Gómez-Piqueras
authors.forename: Fernando
authors.initials: F
authors.lastname: García-Alonso
mesh_terms: D028744:Ethics Committees, Research / Q000592:standards*; D006805:Human Experimentation / Q000941:ethics*; D006801:Humans; D010353:Patient Education as Topic; D028701:Patient Rights; D010597:Pharmacogenetics / Q000592:standards*; D017410:Practice Guidelines as Topic; D012107:Research Design